Jiangzhong Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 1.40%

Jiangzhong Pharmaceutical Co Ltd (600750) has an Asset Resilience Ratio of 1.40% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥100.09 Million
≈ $14.65 Million USD Cash + Short-term Investments

Total Assets

CN¥7.16 Billion
≈ $1.05 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (1997–2025)

This chart shows how Jiangzhong Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Check Jiangzhong Pharmaceutical Co Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Jiangzhong Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Jiangzhong Pharmaceutical Co Ltd (600750) total market value.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥100.09 Million 1.4%
Total Liquid Assets CN¥100.09 Million 1.40%

Asset Resilience Insights

  • Limited Liquidity: Jiangzhong Pharmaceutical Co Ltd maintains only 1.40% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Jiangzhong Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Jiangzhong Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
Drug Manufacturers - Specialty & Generic 0.20%
JW Pharmaceutical Corp
KO:001067
Drug Manufacturers - Specialty & Generic 8.17%
Jiangsu Hengrui Medicine Co Ltd
SHG:600276
Drug Manufacturers - Specialty & Generic 0.16%
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
Drug Manufacturers - Specialty & Generic 11.60%
Guilin Sanjin Pharmaceutical Co Ltd
SHE:002275
Drug Manufacturers - Specialty & Generic 14.80%
Fuan Pharmaceutical Group Co
SHE:300194
Drug Manufacturers - Specialty & Generic 1.34%
DRI Healthcare Trust
TO:DHT-U
Drug Manufacturers - Specialty & Generic 13.91%
Hainan Shuangcheng Pharmaceut
SHE:002693
Drug Manufacturers - Specialty & Generic 1.03%

Annual Asset Resilience Ratio for Jiangzhong Pharmaceutical Co Ltd (1997–2025)

The table below shows the annual Asset Resilience Ratio data for Jiangzhong Pharmaceutical Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 1.38% CN¥95.10 Million
≈ $13.92 Million
CN¥6.88 Billion
≈ $1.01 Billion
+1.23pp
2024-12-31 0.15% CN¥10.01 Million
≈ $1.46 Million
CN¥6.51 Billion
≈ $952.32 Million
-0.63pp
2023-12-31 0.78% CN¥50.02 Million
≈ $7.32 Million
CN¥6.40 Billion
≈ $936.73 Million
-21.09pp
2022-12-31 21.87% CN¥1.37 Billion
≈ $200.89 Million
CN¥6.28 Billion
≈ $918.41 Million
-6.93pp
2021-12-31 28.81% CN¥1.73 Billion
≈ $252.82 Million
CN¥6.00 Billion
≈ $877.64 Million
+8.88pp
2020-12-31 19.92% CN¥980.89 Million
≈ $143.54 Million
CN¥4.92 Billion
≈ $720.47 Million
+6.18pp
2019-12-31 13.74% CN¥654.07 Million
≈ $95.71 Million
CN¥4.76 Billion
≈ $696.42 Million
-9.83pp
2018-12-31 23.58% CN¥899.96 Million
≈ $131.69 Million
CN¥3.82 Billion
≈ $558.54 Million
+23.50pp
2003-12-31 0.08% CN¥800.00K
≈ $117.07K
CN¥986.94 Million
≈ $144.42 Million
-1.33pp
2000-12-31 1.41% CN¥10.00 Million
≈ $1.46 Million
CN¥708.47 Million
≈ $103.67 Million
-1.01pp
1997-12-31 2.42% CN¥9.98 Million
≈ $1.46 Million
CN¥412.00 Million
≈ $60.29 Million
--
pp = percentage points

About Jiangzhong Pharmaceutical Co Ltd

SHG:600750 China Drug Manufacturers - Specialty & Generic
Market Cap
$2.33 Billion
CN¥15.89 Billion CNY
Market Cap Rank
#5660 Global
#1055 in China
Share Price
CN¥25.00
Change (1 day)
-1.26%
52-Week Range
CN¥21.21 - CN¥27.69
All Time High
CN¥561.13
About

China Resources Jiangzhong Pharmaceutical Co.,Ltd engages in the manufacture of pharmaceutical products in China. The company offers OTC products, including stomach-strengthening and digestion-promoting tablets, lactobacillus tablets, triple live bifidobacterium enteric-coated capsules, compound fresh bamboo juice liquid, compound coral lozenges, multivitamin tablets, fritillaria and loquat capsu… Read more